SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-032338
Filing Date
2023-03-14
Accepted
2023-03-14 17:00:47
Documents
1
Period of Report
2023-03-12

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm239588-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm239588-2_4seq1.xml 4 3495
  Complete submission text file 0001104659-23-032338.txt   5158
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Issuer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 787 SEVENTH AVENUE, 48TH FLOOR NEW YORK NY 10019
Business Address
Power Sean A (Reporting) CIK: 0001538845 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32639 | Film No.: 23731840